EGF and nasopharyngeal carcinoma: In this context, our findings illustrated that TEVs-delivered miR-142-5p targeted HGF and EGF to disrupt the HGF/c-Met and EGF/EGFR pathways, ultimately diminishing NPC cell radioresistance to inhibit cell proliferation and facilitate cell apoptosis.